Skip to main content
Michael Wechsler, MD, Pulmonology, Denver, CO, National Jewish Health

MichaelEphraimWechslerMD

Pulmonology Denver, CO

Critical Care Medicine, Pleural Disease

Director of Asthma - Dept of Medicine, National Jewish Health

Dr. Wechsler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wechsler's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/BIDMC/Harvard Medical School
    Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1993 - 1996
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1993

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2012 - 2025
  • MA State Medical License
    MA State Medical License 1995 - 2018
  • FL State Medical License
    FL State Medical License 2013 - 2015
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • American Association of Physicians AAP, 2022
  • Elected Member The American Society for Clinical Investigation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features  
    Zachary M Dong, Michael E Wechsler, Praveen Akuthota, Peter A Merkel, Ulrich Specks, Benjamin Raby, Frederic Clayton, The American Journal of Pathology
  • Baseline Patient Factor Impact on the Clinical Efficacy of Benralizumab for Severe Asthma  
    James G Zangrilli, Michael E Wechsler, The European Respiratory Journal
  • Care Pathways for the Selection of a Biologic in Severe Asthma  
    Michael E Wechsler, Wanda Phipatanakul, Nicola A Hanania, The European Respiratory Journal

Press Mentions

  • Team Effort: A Multidisciplinary Approach to Severe Asthma Control
    Team Effort: A Multidisciplinary Approach to Severe Asthma ControlOctober 4th, 2022
  • Many Patients with Chronic Conditions May Have Low Antibodies After Second COVID-19 Vaccine
    Many Patients with Chronic Conditions May Have Low Antibodies After Second COVID-19 VaccineFebruary 21st, 2022
  • New Monoclonal Antibody Shows Promise for Severe Asthma
    New Monoclonal Antibody Shows Promise for Severe AsthmaOctober 27th, 2021
  • Join now to see all

Grant Support

  • Anti- IL5 Therapy For Churg-Strauss Syndrome: A Double Blind Randomized, Placebo-National Institute Of Allergy And Infectious Diseases2010
  • The Reliability Of The Placebo Effect In AsthmaNational Center For Complementary &Alternative Medicine2006–2007
  • Polymorphisms Of Neural NOS And The Asthma PhenotypeNational Heart, Lung, And Blood Institute2001–2005

Hospital Affiliations